June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Success Isolation of Human Corneal Endothelial Cells for Clinical Use
Author Affiliations & Notes
  • Jin San Choi
    Wake Forest Institute for Regenerative Medicine, Wake Forest University Health Sciences, Winston-Salem, NC
    Oular Systems, INC, Winston-Salem, NC
  • Matthew Giegengack
    Wake Forest Institute for Regenerative Medicine, Wake Forest University Health Sciences, Winston-Salem, NC
    Department of Ophthalmology, Wake Forest School of Medicine, Winston-Salem, NC
  • Eun Young Kim
    BIN Fusion Technology, Chonbuk National University, Jeonju, Republic of Korea
  • Min Jeong Kim
    BIN Fusion Technology, Chonbuk National University, Jeonju, Republic of Korea
  • Ralph D'Agostino
    Public Health Sciences-Department of Biostatistics, Wake Forest School of Medicine, Winston-Salem, NC
  • Gilson Khang
    BIN Fusion Technology, Chonbuk National University, Jeonju, Republic of Korea
  • Shay Soker
    Wake Forest Institute for Regenerative Medicine, Wake Forest University Health Sciences, Winston-Salem, NC
  • Footnotes
    Commercial Relationships Jin San Choi, Ocular Systems, INC (E); Matthew Giegengack, None; Eun Young Kim, None; Min Jeong Kim, None; Ralph D'Agostino, None; Gilson Khang, None; Shay Soker, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 1647. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Jin San Choi, Matthew Giegengack, Eun Young Kim, Min Jeong Kim, Ralph D'Agostino, Gilson Khang, Shay Soker; Success Isolation of Human Corneal Endothelial Cells for Clinical Use. Invest. Ophthalmol. Vis. Sci. 2013;54(15):1647.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Corneal transplantation is a common transplant procedure to improve visual acuity by replacing the opaque or distorted host tissue by clear healthy donor tissue. However, its clinical utility is limited due to a lack of donor supply with high quality corneas. Bioengineered neo-corneas, created using an expandable population of human donor-derived corneal endothelial cells (HCECs), could address this shortage. Thus, the objective of this study was to evaluate HCEC sourcing with various isolation methods, including enzymatic digestion, culture medium components, and adhesive proteins.

Methods: HCECs were obtained from corneas with various aged donors after endothelial keratoplasty. Under a dissection microscope, the Descemet’s membrane, including the attached corneal endothelium was stripped from the stroma and the cells were isolated and expanded by explant culture and the use of enzymatic digestion with enzyme such as collagenase II, dispase, or trypsin. In order to improve the initial cell attachment, tissue culture plates were coated with collagen IV, fibronectin, or fibronectin-collagen combination coating mix (FNC) before cell plating.

Results: In results, HCECs were successfully isolated from 32% (86/269) of donor corneas. Donor age and isolation method influenced the characteristics of the resulting in vitro HCEC culture. Under all conditions tested, FNC-coated plates showed higher quality cultures than other coatings tested.

Conclusions: The results suggest that donor and isolation method characteristics are the two factors that most directly affect the quality of the resulting HCEC in vitro culture. These factors should guide the clinical expansion of HCECs for the generation of bioengineered neo-corneas.

Keywords: 481 cornea: endothelium  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×